Authors



Rajesh Talpade

Latest:

How Artificial Intelligence Impacts the Global Regulatory Environment

Responsible data handling, the impact of mishandling data, and how organizations can implement ethical data best practices.


Audrey Brussel

Latest:

Challenges When Outsourcing Viral Safety Services

Assessing biosafety using NGS-based tests requires a continuum of skills in molecular biology, biocomputing, virology, and quality systems.


Federico Colombari

Latest:

1VQ Solutions: Replace Identity (ID) Testing of Incoming Liquid Drug Substance with ID by Visual Verification

A Post Approval Change (PAC) to replace identity (ID) testing of incoming liquid drug substance with ID by visual inspection is considered a low risk provided questioned listed in this example have been answered favorably. In that case the PAC can be downgraded from a prior approval to a notification to health authorities, and managed in the PQS with immediate implementation effect.



Christina Bucci-Rechtweg

Latest:

Extrapolating Data from Adult Clinical Trials to Advance Pediatric Drug Development

Extrapolating data from adult clinical trials to a pediatric population is a proven method to avoid unnecessary pediatric clinical trials. Representatives of the Pediatric Working Group of the IQ Consortium share case studies that demonstrate how adult clinical trial data can be used to support the dose selection and regimen—or waive the need for a placebo control arm—for pediatric studies.



Spotsee

Latest:

Medical Devices Case Study

On average, cargo is handled seven times between a manufacturer and a client. As medical equipment moves through the supply chain and hospitals, it can experience mishandling which effects the performance and calibration of the product. With medical devices becoming increasingly sophisticated, they’re more likely to be damaged unless proper precautions are taken. RFID impact indicators alert teams to possible damage due to impact as well as track equipment in use, lowering the loss of due to misplaced or stolen devices.


Chad Andersen

Latest:

Best Practice Tech Transfer Methods for CGTs

A look at using best practice tech transfer methods for CGTs to increase process and analytics robustness while being scalable.


Anne Greene

Latest:

Subjectivity in Quality Risk Management

The authors discuss subjectivity in the ICH Q9 (R1) guidance document.


Adare

Latest:

2020 Bio/Pharma Virtual Congress

*** Live: Wednesday, November 11, 2020 | 8:30 AM EDT – 4:00 PM EDT *** 2020 Bio/Pharma Virtual Congress: Join Pharmaceutical Technology® and BioPharm International® for this online event that will explore the latest developments in formulation, manufacturing, and innovative drug dosage forms, as well as detailed discussions about crucial topics impacting the industry. ***On demand available after final airing until 11/11/2021***


Daria G. Husni

Latest:

Facility Design Considerations

John Bertagnolli, vice-president of Commercial Operations at Selkirk Pharma, discusses considerations when building and scaling up pharmaceutical facilities, including contamination control and aseptic processing challenges.


Margaret M. Faul

Latest:

Viewpoint: Precompetitive Collaboration Drives Pharma Industry Innovation

The IQ Consortium marks a decade of impactful innovation of collaboration through a network of pharmaceutical companies driving change for the bio/pharmaceutical industry.


Tetsuya Moritake

Latest:

Proposing a New Method of Detecting Pinholes in Single-Use

The increased use of single-use bags in biologic manufacturing poses the risk of pinholes and other defects that cannot currently be tested for.


Anja Tessarz

Latest:

Viral Clearance Studies: Challenges and Beyond

The design of viral clearance studies must keep pace with the quickly evolving biologic drugs industry.


Ben Moree

Latest:

Biologics Quality Control: The Growing Need for Accessible Proteomics

There is a great need for sensitive, precise, and easily accessible analytical detection techniques for protein sequencing.


Anna Maria Bertasa

Latest:

Specialty Polymers Add Value to Single-use Technologies for Biopharmaceutical Processing

Specialty polymers demonstrate the advantages of single-use consumables in biopharmaceutical manufacturing.


William Tran

Latest:

Right the First Time: Bioreactor Scale and Design Translation

The authors give an overview of scaling approaches and present good scaling practices for the biopharma industry.


Sarah Bergman

Latest:

Strategy for Derivation and Optimization of a Clonal HEK293 Suspension Cell Line for High Yield AAV Production

This commentary summarizes the derivation of clonal HEK293 suspension cell lines, selection of clones for rAAV production, and design of experiments-based optimization strategies for characterization of one clonal isolate for high yield rAAV manufacture. Data shown provides proof of concept for the success of this strategy, its applicability for manufacturing different rAAV serotypes and lays the foundation of further clonal cell line characterization for scale up of production.


Cheryl Barton

Latest:

Frontrunners in Automated Cell and Gene Therapy Manufacturing

Innovative solutions are making personalized cell and gene therapies accessible to all.


Kate Rice

Latest:

Focusing on Effectiveness for CAPAs

Compliance can be greatly improved by concentrating on the basic elements of CAPA investigations, advises Kate Rice, global quality systems manager, Nelson Laboratories, and Susan J. Schniepp, distinguished fellow, Regulatory Compliance Associates.


Antonio Cardillo

Latest:

Purification of Protein by HIC: Mechanistic Modeling for Improved Understanding and Process Optimization

In this article, a simple chromatographic model is proposed that is capable of predicting the impact of pH and ionic strength on HIC chromatograms.


Thermo Fisher Scientific Pharma Services Group

Latest:

Transforming CDMO partnerships through quality

This whitepaper explores the criteria for defining true quality in a CDMO partnership, including multiple product, process, and relationship variables


Catherine Liloia

Latest:

Development Strategies for Cell and Gene Therapy Methods

The increased number of regulatory filings for cell and gene therapies requires reevaluation of bioassay methods because of their complexity.


Molecular Devices

Latest:

Sensitive fluorescent quantitation of DNA with the Quant-iT PicoGreen dsDNA Assay Kit

Here, we demonstrate how you can reliably measure concentrations as low as 50 pg/mL of double-stranded DNA with our SpectraMax® Multi-Mode Microplate Readers and the Quant-iT Pico Green assay.


Philip Dormitzer, MD-PhD

Latest:

The First Optimized Self-Replicating RNA (srRNA) Technology

This inaugural edition of the Pivotal Paper series features leading vaccine experts discussing a groundbreaking study on next-generation self-replicating RNA (srRNA) vaccine technology. The panel explores the study’s key findings, highlighting srRNA’s potential for lower-dose, single-dose vaccines with enhanced immune response, expanding the applications beyond infectious diseases.



Tyler Harris

Latest:

Automated Inspection of Pre-filled Syringes and Biologics During Fill/Finish

Shifts in pharmaceutical packaging have spurred tremendous growth in the pre-filled syringe fill/finish industry.



Oliver Excell

Latest:

Overcoming Engineering Challenges to Enable Commercial Scale mRNA Vaccine Manufacturing

This article provides an overview of solutions to address key challenges facing vaccine developers or CDMOs wishing to build their own commercial-scale mRNA production facilities.

© 2025 MJH Life Sciences

All rights reserved.